Stanford Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
Pilot Projects
On This Page
Internal funding opportunity for established investigators (Stanford faculty with UTL, MCL or NTLR appointments). Preference will be given to those investigators who are not currently involved with CCNE-T.
Deadline: Monday, July 23, 2012 (see "Submitting an Application" below)
Amount of Funding/Budget Information:
Applicants may request $26,000 in total direct costs for a 1-year duration of the supplemental Pilot Projects under this program.
Up to 2 applicants will be selected for funding. Each Pilot Project will be a 1-year duration project and continuation of a project beyond its first year will be contingent upon the success of the previous year. Once all required documents are received, the selected candidates will have a funding period from 8/1/2012 – 7/31/2013.
Eligibility
Established investigators (Stanford faculty with UTL, MCL or NTLR appointments).
Preference will be given to those investigators who are not currently involved with CCNE-T.
All applications, regardless of relationship to CCNE-T, will undergo the same level of scrutiny before being identified as an appropriate Pilot Project.
Purpose
The Center for Cancer Nanotechnology Excellence and Translation (CCNE-T), a U54 grant funded by NIH/NCI, is soliciting new Pilot Projects from established investigators. The vision of CCNE-T is to bring together researchers from various disciplines to form synergistic teams that will make significant advances in developing and validating nanotechnology that will impact cancer diagnosis, therapy and management. Members of these teams will include trainees that will gain access to a highly multidisciplinary experience, and who will become well equipped to establish independent, multidisciplinary research programs. Projects will mainly include those that have a high potential for linking nanotechnology to diagnostic/theranostic devices or to pre-clinical imaging models for improved cancer patient management. The focus of CCNE-T is not on cancer therapeutics or experiemental drugs, hence, project proposals with single focus area of therapeutics are not suitable for this solicitation.
Contact/Questions? Applicants are welcome to discuss their research plans in response to this solicitation with Dr. Demir Akin (demir.akin@stanford.edu).
If selected and funded
Funding is contingent upon receipt of all required documents and protocols, hence, verification of approved protocols must be submitted to Billie Robles at the Department of Radiology. An interim and yearly progress report in NIH format will also be due to Billie Robles. The due dates will be provided upon selection of applicants. Attendances to several CCNE meetings are required to show progress of project. In addition, a presentation of progress is required for the annual NCI site visit, which is held sometime in early 2013.
Submitting an Application
By Monday, July 23, 2012, please submit a PDF file containing a
complete application package (in the order listed below) via email attachment to:
Billie Robles
brobles@stanford.edu
Department Radiology
(Selection process: The CCNE-T Executive Council will review and recommend action on all Pilot Project applications. Candidates will receive a notification of our selection by Monday, August 6, 2012.)
The contents and the format of the application materials are as follows (1-4):
1) Title page with the following information:
Proposed Project title:
Project leader(s):
Name (Last, First and Middle) |
Degrees |
Academic Title |
Department(s) |
Full Contact Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
Co-Investigators:
Name (Last, First and Middle) |
Degrees |
Academic Title(s) |
Department(s) |
Full Contact Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
Please answer all of the questions below
Does your project involve/require the following?
1) Human Subjects? |
Yes |
No |
2) Cancer Related Research? |
|
|
3) Human Stem Cells? |
|
|
4) Human Blood or Body Fluids? |
|
|
5) Vertebrate Animals? |
|
|
6) Radiological Hazards? |
|
|
7) Recombinant DNA Molecules? |
|
|
8) Infectious/Biohazardous Agents? |
|
|
9) Select Agents Research? |
|
|
10) Will export-controlled or proprietary information be received on campus? |
|
|
11) Will Stanford personnel hand-carry or ship equipment, components, materials, or software on media internationally? |
|
|
12) Do you* OR anyone* involved in this research who has responsibility for the design, conduct or reporting of the research have a relationship or receive payment for services or have stock or stock options in the proposed sponsor, vendor(s), or subcontractor(s) or in a company that would be interested in the study results but is not sponsoring the study? |
|
|
2) Research Proposal: 2-6 page (3 page recommended) description of proposed research, including the following:
Research plan.
Description of research subjects involved (human or animal).
Description of interdisciplinary characteristics of this project as how it will utilize the CCNE-T Resources.
Explanation of how the proposed research will link with the existing CCNE-T Projects [see the CCNE-T website at http://mips.stanford.edu/grants/ccne-t/ (note: references are not included in the 6-page limit)
3) Detailed budget for up to $30,000 in total direct costs at applicable rates
Estimated budget period: 8/1/12-07/31/13.
The budget period must end 07/31/13.
Please note: you do not have to have your RPM prepare your budget.
5) Budget Justification (NIH format)
6) Biosketch (NIH format) for the Project Leader and Co-Investigators
7) Other Support (also NIH format). Please include both active and pending support
Note: the release of funds will be contingent upon verification by CCNE-T of the recipient's human subject, SCRO, and animal subject approvals and compliance with other administrative issues.
